Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02–14

BACKGROUND: Mutation of human receptor tyrosine kinase epidermal growth factor receptor-2 (HER2) is a rare event, found in approximately 1% non-small cell lung cancers (NSCLC). The objective was to investigate the clinical characteristics and management of HER2-mutated NSCLCs in a real-life setting....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Ther
Autors principals: Auliac, Jean-Bernard, Dô, Pascal, Bayle, Sophie, Doubre, Hélène, Vinas, Florent, Letreut, Jacques, Falchero, Lionel, Hauss, Pierre Alexandre, Thomas, Pascal, Chouaid, Christos
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2019
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822870/
https://ncbi.nlm.nih.gov/pubmed/31154630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01001-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars